Patients with implanted deep brain stimulation devices to treat movement disorders, neuropsychiatric disorders or epilepsy face unique challenges for device management during the COVID-19 pandemic.
A new commentary published online April 24 in the Journal of Parkinson’s Disease, co-authored Michael S. Okun, M.D., chair of the department of neurology in the UF College of Medicine, offers recommendations aimed at improving DBS patient safety and helping guide appropriate use of health care resources.